These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23098424)

  • 1. Exon 8-9 mutations of DNA polymerase β in ovarian carcinoma patients from Haldia, India.
    Khanra K; Panda K; Mitra AK; Sarkar R; Bhattacharya C; Bhattacharya N
    Asian Pac J Cancer Prev; 2012; 13(8):4183-6. PubMed ID: 23098424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a newly identified variant of DNA polymerase beta (polβΔ63-123, 208-304) with the risk factor of ovarian carcinoma in India.
    Khanra K; Bhattacharya C; Bhattacharyya N
    Asian Pac J Cancer Prev; 2012; 13(5):1999-2002. PubMed ID: 22901161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of two polymorphisms of DNA polymerase beta in exon-9 and exon-11 with ovarian carcinoma in India.
    Khanra K; Panda K; Bhattacharya C; Mitra AK; Sarkar R; Bhattacharyya N
    Asian Pac J Cancer Prev; 2012; 13(4):1321-4. PubMed ID: 22799326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.
    Niwa K; Itoh M; Murase T; Morishita S; Itoh N; Mori H; Tamaya T
    Br J Cancer; 1994 Dec; 70(6):1191-7. PubMed ID: 7981076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.
    Rahman M; Nakayama K; Rahman MT; Nakayama N; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Otsuki Y; Nakayama S; Miyazaki K
    Anticancer Res; 2013 Jan; 33(1):113-8. PubMed ID: 23267135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between newly identified variant form of DNA polymerase beta (Δ 208-304) and ovarian cancer.
    Khanra K; Panda K; Bhattacharya C; Mitra A; Sarkar R; Banerjee S; Bhattacharyya N
    Cancer Biomark; 2012; 11(4):155-60. PubMed ID: 23144153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.
    Lin WL; Kuo WH; Chen FL; Lee MY; Ruan A; Tyan YS; Hsu JD; Chiang H; Han CP
    Ann Surg Oncol; 2011 Aug; 18(8):2388-94. PubMed ID: 21347793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvessel density and p53 mutations in advanced-stage epithelial ovarian cancer.
    Nadkarni NJ; Geest KD; Neff T; Young BD; Bender DP; Ahmed A; Smith BJ; Button A; Goodheart MJ
    Cancer Lett; 2013 Apr; 331(1):99-104. PubMed ID: 23268330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Somatic Mutation in Exon 12 of DNA Polymerase β in Ovarian Cancer Tissue Samples.
    Khanra K; Choudhuri I; Bhattacharyya N
    Iran Biomed J; 2018 Sep; 22(5):355-9. PubMed ID: 29524322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkin gene alterations in ovarian carcinoma from northern Indian population.
    Mehdi SJ; Ali A; Rizvi MM
    Pathol Oncol Res; 2011 Sep; 17(3):579-86. PubMed ID: 21221875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
    Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
    Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.
    Hanley GE; McAlpine JN; Miller D; Huntsman D; Schrader KA; Blake Gilks C; Mitchell G
    BMC Cancer; 2018 Mar; 18(1):254. PubMed ID: 29506471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular alterations in endometrial and ovarian clear cell carcinomas: clinical impacts of telomerase reverse transcriptase promoter mutation.
    Huang HN; Chiang YC; Cheng WF; Chen CA; Lin MC; Kuo KT
    Mod Pathol; 2015 Feb; 28(2):303-11. PubMed ID: 25081752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatase and Tensin Homolog Is a Potential Target for Ovarian Cancer Sensitization to Cytotoxic Agents.
    McCormick A; Earp E; Leeson C; Dixon M; O'Donnell R; Kaufmann A; Edmondson RJ
    Int J Gynecol Cancer; 2016 May; 26(4):632-9. PubMed ID: 26905328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease.
    Kupryjanczyk J; Thor AD; Beauchamp R; Poremba C; Scully RE; Yandell DW
    Mod Pathol; 1996 Mar; 9(3):166-73. PubMed ID: 8685209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1.
    Rudd ML; Mohamed H; Price JC; O'Hara AJ; Le Gallo M; Urick ME; ; Cruz P; Zhang S; Hansen NF; Godwin AK; Sgroi DC; Wolfsberg TG; Mullikin JC; Merino MJ; Bell DW
    BMC Cancer; 2014 Nov; 14():884. PubMed ID: 25427824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.